GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer

INTRODUCTION: Tamoxifen is widely used to treat hormone-dependent breast cancer, but its therapeutic benefit is limited by the development of drug resistance. Here, we investigated the role of estrogen G-protein coupled receptor 30 (GPR30) on Tamoxifen resistance in breast cancer. METHODS: Primary t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mo, Zhiqiang, Liu, Manran, Yang, Fangfang, Luo, Haojun, Li, Zhenhua, Tu, Gang, Yang, Guanglun
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978564/
https://ncbi.nlm.nih.gov/pubmed/24289103
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados